High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Qin, Jing ^a   Yu, Zhenqian ^a   Guan, Haixia ^a   Shi, Liangfeng ^b   Liu, Yongping ^a   Zhao, Na ^a   Shan, Zhongyan ^a   Han, Cheng ^a   Li, Yushu ^a   Teng, Weiping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; AUTOANTIBODY; THYROGLOBULIN; TUMOR MARKER;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; DIFFERENTIATED THYROID CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID NODULE; THYROID SURGERY; TUMOR INVASION; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; THYROID TUMOR;

ADULT; AUTOANTIBODIES; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 84947475067     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/648670     Document Type: Article

References (37)

1. C. Zhu, T. Zheng, B. A. Kilfoy et al. "A birth cohort analysis of the incidence of papillary thyroid cancer in the united states, 1973-2004"Thyroid, vol. 19, no. 10, pp. 1061-1066, 2009
2. R. Siegel, D. Naishadham, and A. Jemal"Cancer statistics, 2012"CA: A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10-29, 2012
3. L. Shi, Y. Li, H. Guan et al. "Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1, 870Chinese patientswith thyroid nodules"Endocrine Journal, vol. 59, no. 11, pp. 973-980, 2012
4. F. A. Verburg, U. Mader, M. Luster, and C. Reiners"Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth andmetastases"European Journal of Endocrinology, vol. 160, no. 4, pp. 619-624, 2009
5. A. Y. Chen, A. Jemal, and E. M. Ward"Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005"Cancer, vol. 115, no. 16, pp. 3801-3807, 2009
6. L. Davies and H. G. Welch"Increasing incidence of thyroid cancer in the United States, 1973-2002"The Journal of the American Medical Association, vol. 295, no. 18, pp. 2164-2167, 2006
7. L. Yip"Molecular diagnostic testing and the indeterminate thyroid nodule"Current Opinion in Oncology, vol. 26, no. 1, pp. 8-13, 2014
8. L. Hegedus"Clinical practice. The thyroid nodule"The New England Journal ofMedicine, vol. 351, no. 17, pp. 1764-1771, 2004
9. D. S. Cooper, G. M. Doherty, B. R. Haugen et al. "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer"Thyroid, vol. 19, no. 11, pp. 1167-1214, 2009
10. K. Boelaert, J. Horacek, R. L. Holder, J. C. Watkinson, M. C. Sheppard, and J. A. Franklyn"Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration"Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4295-4301, 2006
11. D. S. A. McLeod, K. F. Watters, A. D. Carpenter, P. W. Ladenson, D. S. Cooper, and E. L. Ding"Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response metaanalysis"The Journal of Clinical Endocrinology &Metabolism, vol. 97, no. 8, pp. 2682-2692, 2012
12. E. Fiore and P. Vitti"Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease"Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1134-1145, 2012
13. F. Boi, M. L. Lai, B. Marziani, L. Minerba, G. Faa, andS. Mariotti"High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies"European Journal of Endocrinology, vol. 153, no. 5, pp. 637-642, 2005
14. C. A. Spencer, M. Takeuchi, M. Kazarosyan et al. "Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma"Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 4, pp. 1121-1127, 1998
15. E. S. Kim, D. J. Lim, K. H. Baek et al. "Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules"Thyroid, vol. 20, no. 8, pp. 885-891, 2010
16. F. Boi, L. Minerba, M. L. Lai et al. "Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules"Journal of Endocrinological Investigation, vol. 36, no. 5, pp. 313-320, 2013
17. B. Jankovic, K. T. Le, and J. M. Hershman"Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?" Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 2, pp. 474-482, 2013
18. D. S. A. Mcleod, D. S. Cooper, P. W. Ladenson et al. "Prognosis of differentiated thyroid cancer in relation to serumthyrotropin and thyroglobulin antibody status at time of diagnosis, "Thyroid, vol. 24, no. 1, pp. 35-42, 2014
19. S. Smooke-Praw, K. Ro, O. Levin, P. H. G. Ituarte, A. Harari, and M. W. Yeh"Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer"Clinical Endocrinology, vol. 81, no. 2, pp. 271-275, 2014
20. G. Azizi, J. M. Keller, M. Lewis et al. "AssociationofHashimoto's thyroiditis with thyroid cancer"Endocrine-Related Cancer, vol. 21, no. 6, pp. 845-852, 2014
21. H. Guan, Z. Shan, X. Teng et al. "Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes"Clinical Endocrinology, vol. 69, no. 1, pp. 136-141, 2008
22. C. A. Spencer, I. Petrovic, S. Fatemi, and J. LoPresti"Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and falsepositive serum thyroglobulin autoantibody misclassifications"The Journal of Clinical Endocrinology &Metabolism, vol. 99, no. 12, pp. 4589-4599, 2014
23. Y. Li, D. Teng, Z. Shan et al. "Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes"Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1751-1757, 2008
24. Y. S. Li, Z. Y. Shan, H. X. Guan et al. "Determination of cutoff points of thyroid peroxidase antibody and thyroglobulin antibody and their clinical significance"Chinese Journal of Laboratory Medicine, vol. 9, pp. 780-783, 2006 (Chinese)
25. M. E. Dailey, S. Lindsay, and R. Skahen"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland"AMA Archives of Surgery, vol. 70, no. 2, pp. 291-297, 1955
26. K.-C. Loh, F. S. Greenspan, F. Dong, T. R. Miller, and P. P. B. Yeo"Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma"Journal of Clinical Endocrinology andMetabolism, vol. 84, no. 2, pp. 458-463, 1999
27. H. X. Guan, Z. Y. Shan, X. Y. Mi, E. H. Wang, and W. P. Teng"Incidence of thyroid carcinoma before and after universal salt iodization: an 11-year retrospective analysis of pathological reports"Journal of China Medical University, vol. 35, no. 3, pp. 284-285, 2006 (Chinese)
28. S. L. Souza, L. V. Montalli da Assumpcao, and L. S. Ward"Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer"Thyroid, vol. 13, no. 5, pp. 491-495, 2003
29. B.-Y. Huang, C. Hseuh, T.-C. Chao, K.-J. Lin, and J.-D. Lin"Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence"Endocrine Pathology, vol. 22, no. 3, pp. 144-149, 2011
30. W. G. Kim, J. H. Yoon, W. B. Kim et al. "Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma, "The Journal of Clinical Endocrinology &Metabolism, vol. 93, no. 12, pp. 4683-4689, 2008
31. J. H. Seo, S. W. Lee, B.-C. Ahn, and J. Lee"Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F-FDG PET/CT"Clinical Endocrinology, vol. 72, no. 4, pp. 558-563, 2010
32. G. A. Lupoli, O. E. Okosieme, C. Evans et al. "Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer"The Journal of Clinical Endocrinology &Metabolism, vol. 100, no. 1, pp. 100-108, 2015
33. T. Rago, E. Fiore, M. Scutari et al. "Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease"European Journal of Endocrinology, vol. 162, no. 4, pp. 763-770, 2010
34. K. Raparia, S. K. Min, D. R. Mody, R. Anton, and M. Amrikachi"Clinical outcomes for "suspicious" category in thyroid fineneedle aspiration biopsy: patient's sex and nodule size are possible predictors of malignancy"Archives of Pathology and Laboratory Medicine, vol. 133, no. 5, pp. 787-790, 2009
35. C. C. Lubitz, W. C. Faquin, J. Yang et al. "Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms"Thyroid, vol. 20, no. 1, pp. 25-31, 2010
36. M. R. Castro, R. P. Espiritu, R. S. Bahn et al. "Predictors of malignancy in patients with cytologically suspicious thyroid nodules"Thyroid, vol. 21, no. 11, pp. 1191-1198, 2011
37. S. C. Kamran, E. Marqusee, M. I. Kim et al. "Thyroid nodule size and prediction of cancer"The Journal of Clinical Endocrinology &Metabolism, vol. 98, no. 2, pp. 564-570, 2012.